Orthocell Ltd has released a press release.
Regulatory approval to commence Remplir sales in Singapore
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Orthocell
- Second Consecutive Record Quarter as Revenue Exceeds $2m
- First sales of Striate in major new market of Canada
- Company Presentation
- Regulatory Approval to Commence Sales for Striate in Canada
- Record Quarterly and Yearly Revenue Show Outstanding Growth
Later from Orthocell
- $17m Placement to Drive Further Growth as US Approval Nears
- Orthocell completes $17m Placement
- Key Executives Appointed to Drive Remplir US Sales
- Distributor Signed, Remplir Sales in Singapore to Commence
- Outstanding Remplir Study Results Pave Way for FDA Clearance
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell